Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04622774
Title First-in-Human Study of IMGC936 in Patients With Advanced Solid Tumors
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors ImmunoGen, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | ITA | ESP

Facility Status City State Zip Country Details
UCSD La Jolla California 92037 United States Details
Sarah Cannon Research Institute Denver Colorado 80218 United States Details
Florida Cancer Specialists Sarasota Florida 34232 United States Details
Dana-Farber Cancer Institute Boston Massachusetts 02215 United States Details
Washington University Saint Louis Missouri 63110 United States Details
Stephenson Cancer Center Oklahoma City Oklahoma 73104 United States Details
MD Anderson Cancer Center Houston Texas 77030 United States Details
Policlinico di Modena Modena 41124 Italy Details
IRCCS Humanitas Rozzano 20089 Italy Details
Azienda Ospedaliera Universitaria Senese Siena 53100 Italy Details
START Madrid-FJD Hospital Universitario Fundacion Jimenez Diaz Madrid 28040 Spain Details
START Madrid-HM CIOCC Madrid 28050 Spain Details
Hospital Universitario Quirónsalud Madrid Madrid 28223 Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field